SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The quarter ended March 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 6643.70 millions.Net profit surges 50.79% to Rs. 1092.76  millions  from Rs. 724.70 millions in the quarter ended March 2024.Operating profit for the quarter ended March 2024 rose to 1658.20 millions as compared to 973.89 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 6643.70 6515.73 1.96 28325.41 35109.68 -19.32 28325.41 35109.68 -19.32
Other Income 270.90 165.40 63.78 961.23 450.56 113.34 961.23 450.56 113.34
PBIDT 1658.20 973.89 70.27 5696.10 7126.60 -20.07 5696.10 7126.60 -20.07
Interest 10.24 13.93 -26.49 47.71 53.94 -11.55 47.71 53.94 -11.55
PBDT 1647.96 959.96 71.67 5648.39 7072.66 -20.14 5648.39 7072.66 -20.14
Depreciation 161.41 140.31 15.04 614.92 518.62 18.57 614.92 518.62 18.57
PBT 1486.55 819.65 81.36 5033.47 6554.04 -23.20 5033.47 6554.04 -23.20
TAX 393.79 94.95 314.73 1336.73 1519.67 -12.04 1336.73 1519.67 -12.04
Deferred Tax 2.68 -27.77 -109.65 64.53 4.18 1443.78 64.53 4.18 1443.78
PAT 1092.76 724.70 50.79 3696.74 5034.37 -26.57 3696.74 5034.37 -26.57
Equity 4991.46 4991.46 0.00 4991.46 4991.46 0.00 4991.46 4991.46 0.00
PBIDTM(%) 24.96 14.95 66.99 20.11 20.30 -0.93 20.11 20.30 -0.93

Sumitomo Chemical Share Price

441.95 17.15 (4.04%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×